Since it has been repeatedly reported that LINC00511 principally affects cancer progression by serving as a competing endogenous RNA (ceRNA) via the lncRNA/microRNA (miR)/mRNA axis [13, 14], we hypothesize that LINC00511 could also mediate OA severity through the ceRNA network. This evidence concerns the gene LINC00511 and cancer.